Pen Injectors Market
Pen Injectors Market Forecasts to 2030 - Global Analysis By Type (Disposable and Reusable), Dosage (Fixed Dosage, Variable Dosage, Half-Unit Dosage, Specialized Dosage and Other Dosages), Therapy, Distribution Channel, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $48.82 BN |
|
Projected Year Value (2030) |
US $75.81 BN |
|
CAGR (2023 - 2030) |
9.2% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Pen Injectors Market is accounted for $48.82 billion in 2023 and is expected to reach $75.81 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Pen injectors are medical devices designed to administer precise doses of medication to patients. They are often used for self-injection of various types of medication, including insulin, growth hormones, certain biologic drugs, and other injectables. Pen injectors are widely used by patients with chronic conditions such as diabetes, multiple sclerosis, rheumatoid arthritis, and more. They are designed to be user-friendly, making them easy for patients to handle and administer their medication, even without professional medical assistance.
According to Caspersen et al, in 2020, about 10.9 million people aged above 65 years were estimated to have been diagnosed with diabetes in the U.S, and this number is projected to reach 26.7 million by 2050.
Market Dynamics:
Driver:
Increasing advancements in biologic therapies
Biologic therapies often require precise dosages due to their complex molecular structures and mechanisms of action. Pen injectors are designed to deliver accurate and consistent dosages, making them well-suited for biologic medications. Also, Pen injectors enable patients to self-administer their biologic therapies, reducing the need for frequent visits to healthcare facilities. Additionally, the convenience and ease of use associated with pen injectors can lead to improved patient compliance and adherence to prescribed biologic therapies which fuels the market demand.
Restraint:
Limited compatibility with certain medications
Healthcare providers may be hesitant to prescribe or recommend pen injectors if they are not compatible with a wide range of medications. Patients who require multiple medications, some of which are not compatible with the pen injector, may find it inconvenient or burdensome to use different administration methods. This can lead to decreased patient satisfaction and compliance. Manufacturers may miss out on business opportunities with pharmaceutical companies. This could result in lost partnerships and contracts.
Opportunity:
Integration with digital health solutions
Pen injector’s integration with digital health solutions offers a range of benefits and applications for both patients and healthcare providers. It allows patients to track and monitor their medication doses. Digital health platforms can send reminders and alerts to patients, prompting them to take their medication at the prescribed times. Based on the data collected, healthcare providers can make informed decisions about medication titration or adjustments to optimize treatment outcomes. Further, it also enhances patient engagement, reduces hospitalizations, and provides insights for specific conditions which boost the market growth.
Threat:
Competition from alternative drug delivery methods
Alternative drug delivery methods, such as oral tablets, inhalers, patches, and even newer technologies like smart pills or implantable devices, offer patients a range of options. Some patients may prefer alternative methods of drug delivery over pen injectors with a fear of needles. Further, certain conditions may respond better to inhalable or oral forms of medication compared to injectables. Additionally, innovation and improvements in alternative methods, making them more attractive to patients and healthcare providers which impedes the market growth.
Covid-19 Impact
The pen injectors market, which is a part of the medical device industry, likely experienced both positive and negative effects during the pandemic. The rise of telemedicine and remote monitoring during the pandemic may have influenced the adoption of pen injectors, as they are conducive to self-administration and remote monitoring of chronic conditions. Economic uncertainty and shifts in healthcare priorities may have led to market consolidation. The epidemic has affected the vaccination rates, and the emergence of new variants.
The diabetes segment is expected to be the largest during the forecast period
The diabetes segment is estimated to have a lucrative growth. Pen injectors allow for precise and accurate dosing of insulin, ensuring that individuals receive the correct amount of medication. Pen injectors are compact, lightweight, and easy to carry, making them convenient for individuals who need to administer insulin on the go. They use fine-gauge needles, which can result in less pain and discomfort during injection. Its user-friendly nature, customizable dosing and discreet administration propels the segment demand.
The home-care settings segment is expected to have the highest CAGR during the forecast period
The home-care settings segment is anticipated to witness the highest CAGR growth during the forecast period, due to its convenience and effectiveness. Pen injectors are designed to be user-friendly, often featuring simple mechanisms for loading and administering medication. They are compact and portable, allowing patients to administer their medication at home or on the go. It empowers patients to take control of their own medication regimen. These aspects accelerate the segment growth.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing prevalence of chronic diseases and rising healthcare expenditure. Countries like China, Japan, India, South Korea and Australia are major markets for healthcare products and devices due to their large and diverse population. The region has the presence of major key players such as Sanofi, Novo Nordisk and Sun Pharmaceutical Industries. Additionally, some governments in the Asia Pacific region have implemented policies and initiatives to promote the use of advanced medical devices, which has positively impacted the market for pen injectors.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of chronic diseases, the trend towards self-administration of drugs, and advancements in pen injector technology. Increasing incidence of diabetes and growing obese population is contributing toward market growth. The market is competitive with several key players such as Antares Pharma and Becton, Dickinson & Company. Further, technological advancements, the presence of a wide distribution network and increase in geriatric population, which require safer delivery devices, are other factors driving the North America market.
Key players in the market
Some of the key players profiled in the Pen Injectors Market include AstraZeneca, Becton, Dickinson and Company, Merck Group, Pfizer Inc., Eli Lilly and Company, Novartis AG, Sanofi, Novo Nordisk A/S, Biocon, Medtronic, Terumo Medical Corporation, Sun Pharmaceutical Industries Limited, GlaxoSmithKline PLC, Mylan N.V., Novo Nordisk, Owen Mumford Limited and Phillips-Medisize.
Key Developments:
In February 2023, Phillips-Medisize announced an addition to its portfolio of drug delivery devices, with its pen injector platform that is described as being more affordable to produce. The pen injector has been designed to match user expectation and experiences with disposable pen products, the company added.
In January 2023, Sun Pharmaceutical Industries Ltd launched its Phenobarbital sodium injection, SEZABY for treatment of neonatal seizures in the US. SEZABY is the first and only product approved by the US Food and Drug Administration (USFDA) for the treatment of neonatal seizures in term and preterm infants, Sun Pharma said in a regulatory filing.
In September 2022, Medtronic announced the European launch of its Smart MDI system, which combines personalized insulin dosing information from the InPen™ smart insulin pen with the power of predictive glucose alerts from the Guardian™ 4 smart continuous glucose monitoring (CGM) system.
Types Covered:
• Disposable
• Reusable
Dosages Covered:
• Fixed Dosage
• Variable Dosage
• Half-Unit Dosage
• Specialized Dosage
• Other Dosages
Therapies Covered:
• Diabetes
• Growth Hormone
• Osteoporosis
• Fertility
• Arthritis
• Cancer
• Multiple Sclerosis
• Autoimmune Diseases
• Anaphylaxis
• Cardiovascular Diseases
• Other Therapies
Distribution Channels Covered:
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Drug Stores
End Users Covered:
• Home-care Settings
• Hospital & Clinics
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pen Injectors Market, By Type
5.1 Introduction
5.2 Disposable
5.3 Reusable
6 Global Pen Injectors Market, By Dosage
6.1 Introduction
6.2 Fixed Dosage
6.3 Variable Dosage
6.4 Half-Unit Dosage
6.5 Specialized Dosage
6.6 Other Dosages
7 Global Pen Injectors Market, By Therapy
7.1 Introduction
7.2 Diabetes
7.2.1 Insulin
7.2.2 Glucagon-Like-Peptide-1 (GLP-1)
7.3 Growth Hormone
7.4 Osteoporosis
7.5 Fertility
7.6 Arthritis
7.7 Cancer
7.8 Multiple Sclerosis
7.9 Autoimmune Diseases
7.10 Anaphylaxis
7.11 Cardiovascular Diseases
7.12 Other Therapies
8 Global Pen Injectors Market, By Distribution Channel
8.1 Introduction
8.2 Hospital Pharmacies
8.3 Retail Pharmacies
8.4 Online Stores
8.5 Drug Stores
9 Global Pen Injectors Market, By End User
9.1 Introduction
9.2 Home-care Settings
9.3 Hospital & Clinics
10 Global Pen Injectors Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 AstraZeneca
12.2 Becton, Dickinson and Company
12.3 Merck Group
12.4 Pfizer Inc.
12.5 Eli Lilly and Company
12.6 Novartis AG
12.7 Sanofi
12.8 Novo Nordisk A/S
12.9 Biocon
12.10 Medtronic
12.11 Terumo Medical Corporation
12.12 Sun Pharmaceutical Industries Limited
12.13 GlaxoSmithKline PLC
12.14 Mylan N.V.
12.15 Novo Nordisk
12.16 Owen Mumford Limited
12.17 Phillips-Medisize
List of Tables
1 Global Pen Injectors Market Outlook, By Region (2021-2030) ($MN)
2 Global Pen Injectors Market Outlook, By Type (2021-2030) ($MN)
3 Global Pen Injectors Market Outlook, By Disposable (2021-2030) ($MN)
4 Global Pen Injectors Market Outlook, By Reusable (2021-2030) ($MN)
5 Global Pen Injectors Market Outlook, By Dosage (2021-2030) ($MN)
6 Global Pen Injectors Market Outlook, By Fixed Dosage (2021-2030) ($MN)
7 Global Pen Injectors Market Outlook, By Variable Dosage (2021-2030) ($MN)
8 Global Pen Injectors Market Outlook, By Half-Unit Dosage (2021-2030) ($MN)
9 Global Pen Injectors Market Outlook, By Specialized Dosage (2021-2030) ($MN)
10 Global Pen Injectors Market Outlook, By Other Dosages (2021-2030) ($MN)
11 Global Pen Injectors Market Outlook, By Therapy (2021-2030) ($MN)
12 Global Pen Injectors Market Outlook, By Diabetes (2021-2030) ($MN)
13 Global Pen Injectors Market Outlook, By Insulin (2021-2030) ($MN)
14 Global Pen Injectors Market Outlook, By Glucagon-Like-Peptide-1 (GLP-1) (2021-2030) ($MN)
15 Global Pen Injectors Market Outlook, By Growth Hormone (2021-2030) ($MN)
16 Global Pen Injectors Market Outlook, By Osteoporosis (2021-2030) ($MN)
17 Global Pen Injectors Market Outlook, By Fertility (2021-2030) ($MN)
18 Global Pen Injectors Market Outlook, By Arthritis (2021-2030) ($MN)
19 Global Pen Injectors Market Outlook, By Cancer (2021-2030) ($MN)
20 Global Pen Injectors Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
21 Global Pen Injectors Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
22 Global Pen Injectors Market Outlook, By Anaphylaxis (2021-2030) ($MN)
23 Global Pen Injectors Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
24 Global Pen Injectors Market Outlook, By Other Therapies (2021-2030) ($MN)
25 Global Pen Injectors Market Outlook, By Distribution Channel (2021-2030) ($MN)
26 Global Pen Injectors Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
27 Global Pen Injectors Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
28 Global Pen Injectors Market Outlook, By Online Stores (2021-2030) ($MN)
29 Global Pen Injectors Market Outlook, By Drug Stores (2021-2030) ($MN)
30 Global Pen Injectors Market Outlook, By End User (2021-2030) ($MN)
31 Global Pen Injectors Market Outlook, By Home-care Settings (2021-2030) ($MN)
32 Global Pen Injectors Market Outlook, By Hospital & Clinics (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
